OCULAR DRUG DELIVERY: AN OVERVIEW
DOI:
https://doi.org/10.7439/ijbar.v2i5.32Abstract
Ocular drug delivery is one of the most fascinating and challenging tasks facing the Pharmaceutical researchers. One of the major barriers of ocular medication is to obtain and maintain a therapeutic level at the site of action for prolonged period of time. The eye as a portal for drug delivery is generally used for local therapy against systemic therapy to avoid the risk of eye damage from high blood concentration of the drug, which is not intended.Downloads
Download data is not yet available.
Downloads
Published
2011-06-01
Issue
Section
Review Article
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
How to Cite
OCULAR DRUG DELIVERY: AN OVERVIEW. (2011). International Journal of Biomedical and Advance Research, 2(5), 167-187. https://doi.org/10.7439/ijbar.v2i5.32
